Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension

NCT01303783 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01303783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Multifactorial, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of Nifedipine GITS and Candesartan in Combination Compared to Monotherapy in Adult Patients With Essential Hypertension
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2011
Completion date
May 31, 2012
Enrollment
1,381 (actual)
Sites
157

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, essential